Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Clinical Implications
  • Published:

Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Spear BB, Heath-Chiozzi ME, Barnes DM, Cheeseman K, Shaw P, Campbell DA et al . Terminology for sample collection in clinical genetic studies Pharmaco J 2001 1: 101–103

    Article  Google Scholar 

  2. National Bioethics Advisory Commission (USA). Ethical and Policy Issues in Research Involving Human Participants 2001

  3. Knoppers BM . Ethical Issues in International Collaborative Research on the Human Genome: The HGP and the HGDP Genomics 1996 34: 272–282

    CAS  Google Scholar 

  4. Medical Research Council (UK). Human Tissue and Biological Samples for Use in Research (for Consultation) 1999

  5. Council for International Organizations for Medical Sciences. International guidelines for ethical review of epidemiological studies Law Med Health Care 1991 19: 247–258

  6. World Health Organization. Proposed International Guidelines on Ethical Issues in Med-ical Genetics and Genetic Services. (Documentreference WHO/HGN/GL/ETH98.1). Report of a WHO Meeting on Ethical Issues in medical Genetics, Geneva 15–16 December 1997

  7. Human Genome Organization Ethics Committee. Statement on DNA Sampling: Control and Access, 1998. Based on the discussion by the HUGO Ethics Committee of the Knoppers paper Genomics 1998 50: 385–401

    Article  CAS  Google Scholar 

  8. For information on guidelines, policies, lawshttp://www.humgen.umontreal.ca/en/

  9. The American Society of Human Genetics. Statement on informed consent for genetic research Am J Hum Genet 1996 59: 471–474

  10. Reilly PR, Boshar MF, Holtzman SH . Ethical issues in genetic research: disclosure and informed consent Nat Genet 1997 15: 16–20

    Article  CAS  Google Scholar 

  11. Clayton E . Informed consent for genetic research on stored tissue samples JAMA 1995 274: 1786–1792

    Article  CAS  Google Scholar 

  12. Deschenes M, Cardinal G, Knoppers BM, Glass KC . Human genetic research, DNA banking and consent: a question of ‘form’ Clin Genet 2001 59: 221–239

    Article  CAS  Google Scholar 

  13. Beskow MB, Burke W, Merz JF, Barr PA, Rerry S, Penchaszadeh VB et al . Informed consent for population-based research involving genetics JAMA 2001 286: 2315–2326

    Article  CAS  Google Scholar 

  14. 45 Code of Federal Regulations (US), § 46.116

  15. 21 Code of Federal Regulations (US), § 312.62

  16. Earley C, Strong L . Certificates of confidentiality: a valuable tool for protecting genetic data Am J Hum Genet 1995 57: 727–731

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Knoppers BM, Hirtle M, Lormeau S, Laberge CM, Laflamme M . Ethical issues: control of DNA samples and information Genomics 1998 50: 385–401

    Article  CAS  Google Scholar 

  18. Went L . Ethical issues policy statement on Huntington's disease molecular genetics predictive test J Med Genet 1990 27: 34–38

    Article  CAS  Google Scholar 

  19. Reilly PR . Rethinking risks to human subjects in genetic research Am J Hum Genet 1998 63: 682–685

    Article  CAS  Google Scholar 

  20. NIH Office of Protection from Research Risks in Human Genetic Research. Protecting Human Research Subjects: Institutional Review Board Guidebook Chapter 5H US Government Printing Office: Washington, DC 1993

  21. Department of Health and Human Services. Standards for Privacy of Individually Identifiable Health Information, 65 Federal Register 82462, December 28, 2000

  22. Directive 95/46/EC of the European Parliament and of the Council of October 24, 1995 on the protection of individuals with regard to the processing of personal data and on the free movement of such data. Official J Eur Comm 1995 L281: 31–50

  23. American's with Disabilities Act. A Guide to Disability Rights Law US Department of Justice, Civil Rights Division, Disability Rights Section, May 2000.http://www.usdoj.gov/crt/ada/cguide.htm

  24. Knoppers BM . Status, sale and patenting of human genetic material: an international survey Nat Genet 1999 22: 23–26

    Article  CAS  Google Scholar 

  25. Exculpatory Language in Informed Consent. Cooperative Oncology Group Chairpersons Meeting, Office for Protection from Research Risks (OPRR), 1996http://ohrp.osophs.dhhs.gov/humansubjects/guidance/exculp.htm

  26. The Human Genome Organisation. Ethical, legal, and social issues committee on the principled conduct of genetic research Genome Dig 1996 3: 2–3

  27. United Nations Educational, Scientific and Cultural Organization. Draft of a Universal Declaration on the Human Genome and Human Rights International Bioethics Committee: Paris France 1997

  28. Council of Europe. Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine Int Dig Health Legislat 1997 48: 99–105

  29. Council of Europe. Recommendation R (90) 3 on medical research on human beings Int Dig Health Legislat 1990 41: 461

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to DC Anderson.

Additional information

Members of the Pharmacogenetics Working Group include: Abbott Laboratories, Amgen, AstraZeneca, Aventis, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Organon, Pfizer, Pharmacia Corporation, F Hoffmann-La Roche Ltd., Schering AG, Schering-Plough, and Wyeth Research.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anderson, D., Gomez-Mancilla, B., Spear, B. et al. Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group. Pharmacogenomics J 2, 284–292 (2002). https://doi.org/10.1038/sj.tpj.6500131

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500131

This article is cited by

Search

Quick links